The Supreme Court ruled yesterday that companies could not patent human genes. This case focused on the BRCA 1 and 2 genes linked to breast cancer risk, but the U.S. Patent Office has issued patents on thousands of human genes, including genes associated with colon cancer, Alzheimer’s disease, and muscular dystrophy. The unanimous decision was […]
The same market forces that made computers cheaper and faster are influencing the cost of gene mapping. The team at Complete Genomics is using expertise from computer networking experience to build machines that can do genetic sequencing more quickly and more affordably. Complete Genomics is in the race to push the cost of sequencing an […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Last month, my colleague Shane Climie wrote a post inspired by an article in the New York Times (“How Bright Promise in Cancer Testing Fell Apart”), which exposed disturbing and cautionary insights into the application of genetic testing technology. Today, I’m responding to a recent New York Times article in which reporter Andrew Pollack wrote […]